Drugs Reviews | Drugs News

DEA Announces Prescription Drug Take-Back Day to Fight U.S. Drug Abuse In an announcement made last week by the U.S. Drug Enforcement Administration (DEA), a first-ever nationwide public health campaign called the “Take-Back” initiative will be unveiled next month, marking the latest effort by the government agency to combat the rise in prescription drug abuse [...]

Melanoma Patients Respond Favorably to Experimental Drug, Tests Show Findings from a phase I clinical trial showed that a new experimental drug may extend progression-free survival in certain patients suffering from advanced melanoma, the most severe form of skin cancer. The new drug, called PLX4032, appears to offer much greater benefits than current melanoma treatment [...]

Media’s Impact On Teen Sexual Behaviors, Teenage Pregnancies And Sexually Transmitted Infections With the highest teen pregnancy rate in the Western Hemisphere and 25% of teens having had a sexually transmitted infection, we should be paying careful attention to media messages about sexuality and contraception, says a revised policy statement by the American Academy of [...]

Hip Replacement Recall By Depuy Orthopaedics Is Big News Due to a fairly high percentage (12-13%) of five year revision or secondary hip surgeries DePuy Orthopaedics, Inc. reported based on this year’s data from the National Joint Registry (NJR) of England and Wales, the manufacturer announced this week it is voluntarily pulling the ASR™ XL [...]

Charity Encourages Brisk Walking, Being More Active To Prevent Breast And Bowel Cancer, UK A cancer research charity estimates that 10,000 cases of breast and bowel cancer could be prevented every year in the UK if people engaged in more “brisk walking” or were generally more physically active every day. The World Cancer Research Fund [...]

Blood Clot Risk More Than Double In Black Americans Implanted With Drug-Coated Stents A new study found that black Americans implanted with drug-coated stents have more than double the risk of developing life-threatening blood clots than Americans from other races who have also had drug-coated stents implanted to prop open narrowing arteries. You can read [...]

Diabetic Macular Edema Drug Iluvien Gets FDA Priority Review Iluvien(R) (fluocinolone acetonide intravitreal insert), an investigational sustained drug delivery system that releases sub-microgram levels of fluocinolone acetonide for DME (diabetic macular edema) treatment, has been accepted for filing and granted Priority Review States by the FDA (Food and Drug Administration, USA), Alimera Sciences, Inc. announced [...]

GSK, Valeant Pharma receive Ezogabine PDUFA extension date GlaxoSmithKline (GSK) and Valeant Pharma have received an extension of the Prescription Drug User Fee Act (PDUFA) goal date for Ezogabine to 30 November 2010 from the US Food and Drug Administration (FDA), while the initial date being 30 August 2010. Read more about GSK, Valeant Pharma [...]

FDA grants orphan drug status to BioMarin Pharma BMN-701 The US Food and Drug Administration (FDA) has granted orphan drug status to BioMarin Pharmaceutical’s BMN-701 for the treatment of Pompe disease. Read more about FDA grants orphan drug status to BioMarin Pharma BMN-701 No tags for this post.

GW Pharma, Bayer get Health canada approval for Sativex GW Pharmaceuticals and Bayer Inc have received Health canada approval for Sativex as adjunctive treatment for spasticity due to multiple sclerosis (MS). Read more about GW Pharma, Bayer get Health canada approval for Sativex No tags for this post.